News

Biotech Stock News: Izotropic (CSE: IZO) (OTCQB: IZOZF) Updates Timelines for Clinical Study and Fabrication of Initial Izoview Units

Vancouver, British Columbia – June 3, 2021 (Newsfile Corp.) (Investorideas.com Newswire) Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) (“Izotropic” or the “Company”) a Company commercializing “Izoview”, a true 3D, dedicated Breast Computed Tomography (CT) imaging technology for the diagnostic identification of breast cancers, provides updates on the following

What's your reaction?

Excited
0
Happy
0
In Love
0
Not Sure
0
Silly
0

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *

More in:News